These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 29848236)

  • 1. Pharmacology of Adenosine Receptors: The State of the Art.
    Borea PA; Gessi S; Merighi S; Vincenzi F; Varani K
    Physiol Rev; 2018 Jul; 98(3):1591-1625. PubMed ID: 29848236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors.
    Jamwal S; Mittal A; Kumar P; Alhayani DM; Al-Aboudi A
    Curr Pharm Des; 2019; 25(26):2892-2905. PubMed ID: 31333104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinoceptors in the nervous system.
    Fredholm BB
    Pharmacol Toxicol; 1995 Apr; 76(4):228-39. PubMed ID: 7617551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms.
    Jespers W; Schiedel AC; Heitman LH; Cooke RM; Kleene L; van Westen GJP; Gloriam DE; Müller CE; Sotelo E; Gutiérrez-de-Terán H
    Trends Pharmacol Sci; 2018 Jan; 39(1):75-89. PubMed ID: 29203139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.
    Deb PK; Deka S; Borah P; Abed SN; Klotz KN
    Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of P1 (adenosine) purinoceptors.
    Jarvis MF
    Curr Protoc Pharmacol; 2013 Oct; 62():1.9.1-1.9.16. PubMed ID: 24510716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future.
    Borah P; Deka S; Mailavaram RP; Deb PK
    Curr Pharm Des; 2019; 25(26):2792-2807. PubMed ID: 31333097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of adenosine receptor heteromers.
    Franco R; Cordomí A; Llinas Del Torrent C; Lillo A; Serrano-Marín J; Navarro G; Pardo L
    Cell Mol Life Sci; 2021 Apr; 78(8):3957-3968. PubMed ID: 33580270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature.
    Sousa JB; Fresco P; Diniz C; Goncalves J
    Recent Pat Anticancer Drug Discov; 2018; 13(1):40-69. PubMed ID: 29119938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine receptors and Huntington's disease.
    Lee CF; Chern Y
    Int Rev Neurobiol; 2014; 119():195-232. PubMed ID: 25175968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine Receptors as Novel Targets for the Treatment of Various Cancers.
    Gorain B; Choudhury H; Yee GS; Bhattamisra SK
    Curr Pharm Des; 2019; 25(26):2828-2841. PubMed ID: 31333092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Method for Screening Adenosine Receptor Specific Agonists for Use in Adenosine Drug Development.
    Jones KR; Choi U; Gao JL; Thompson RD; Rodman LE; Malech HL; Kang EM
    Sci Rep; 2017 Mar; 7():44816. PubMed ID: 28317879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine receptor desensitization and trafficking.
    Mundell S; Kelly E
    Biochim Biophys Acta; 2011 May; 1808(5):1319-28. PubMed ID: 20550943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular adenosine receptors; potential clinical applications.
    Ho MF; Rose'Meyer RB
    Curr Vasc Pharmacol; 2013 May; 11(3):327-37. PubMed ID: 22724462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Structural Insight into Adenosine A
    Karati D; Mukherjee S; Roy S
    Mol Neurobiol; 2023 Oct; 60(10):5987-6000. PubMed ID: 37391647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain.
    Vincenzi F; Pasquini S; Borea PA; Varani K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases.
    Chen L; Lei X; Mahnke K
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroprotective mechanisms of adenosine action on CNS neurons].
    Zalewska-Kaszubska J
    Neurol Neurochir Pol; 2002; 36(2):329-36. PubMed ID: 12046508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine and Inflammation: Here, There and Everywhere.
    Pasquini S; Contri C; Borea PA; Vincenzi F; Varani K
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.